simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;;;95^{th}-Individual ID 70;95^{th}-Individual ID 70;95^{th}-Individual ID 70;95^{th}-Individual ID 70;95^{th}-Individual ID 70
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.359076703685489;0.346856050691459;-0.264054520535781;-0.669105439192195;0.914848167927644;;;-0.871390938117336;0.619178359817944;-0.841616827323069;-1.44096235741572;3.66606368203017
;-0.373197490229089;0.320634625835569;-0.273496165864578;-0.712790783592197;0.890866268696454;;;-33.4001090699907;-31.8627058936748;-33.3669800021839;-34.0032858080776;-28.7901382088098
;-0.34495591714189;0.37307747554735;-0.254612875206985;-0.625420094792194;0.938830067158833;;;31.657327193756;33.1010626133107;31.6837463475378;31.1213610932461;36.1222655728702
;0.999542128612636;0.998310031752072;0.99962143296372;0.998738946598411;0.999796492792001;;;0.00241680838003466;0.00122522990450669;0.00225530277709718;0.00656770577320853;0.0412943668166454
;4.15875932204324e-06;2.95003390997341e-05;3.12645647211358e-06;1.90131231583741e-05;1.23221098088671e-06;;;0.937431435011103;0.955441536958412;0.939556554086174;0.896927966045296;0.743056709431598
